EGR1 and Alzheimer disease: The top score for Egr1 in the network perturbation analysis, the significant gender-dependent AD associations for this gene across multiple cell types, and its previous functional implications in AD derived from the literature, suggest Egr1 as the main candidate target for further preclinical pharmacological research on reverting male-specific pathological endothelial changes in AD.